Watada Hirotaka, Fujitani Yoshio
Department of Metabolism and Endocrinology (H.W., Y.F.), Centers for Molecular Diabetology (H.W., Y.F.) and Therapeutic Innovations in Diabetes (H.W.), and Japan Science and Technology Agency (JST)-CREST Program (Y.F.), Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.
Mol Endocrinol. 2015 Mar;29(3):338-48. doi: 10.1210/me.2014-1367. Epub 2015 Jan 29.
Autophagy is a conserved system for the degradation of cytoplasmic proteins and organelles. During insulin resistance, in which insulin secretion is enhanced and β-cell mass is increased owing to changes in the expression and function of various proteins in pancreatic β-cells, autophagic activity appears to also be enhanced to adapt to the dynamic changes occurring in β-cells. Indeed, defective autophagy in β-cells recapitulates several features that are observed in islets during the development of type 2 diabetes mellitus. In addition, the dyregulation of autophagic activity appears to occur in the β-cells of type 2 diabetic model mice and type 2 diabetes mellitus patients. These lines of evidence suggest that autophagic failure may be implicated in the pathophysiology of type 2 diabetes mellitus. In this review, we summarized the recent findings regarding how autophagy in β-cells is regulated and how dysfunction of the autophagic machinery may lead to the dysfunction of β-cells.
自噬是一种保守的系统,用于降解细胞质蛋白和细胞器。在胰岛素抵抗期间,由于胰腺β细胞中各种蛋白质的表达和功能发生变化,胰岛素分泌增强且β细胞量增加,自噬活性似乎也会增强,以适应β细胞中发生的动态变化。事实上,β细胞中的自噬缺陷概括了2型糖尿病发展过程中在胰岛中观察到的几个特征。此外,自噬活性的失调似乎发生在2型糖尿病模型小鼠和2型糖尿病患者的β细胞中。这些证据表明,自噬功能障碍可能与2型糖尿病的病理生理学有关。在这篇综述中,我们总结了关于β细胞中的自噬如何被调节以及自噬机制功能障碍如何导致β细胞功能障碍的最新发现。